Sponsor Pipeline

Dan Feng Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
1
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-13 NCT07277322
Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases		 Recruitment opened
Active Trials by Phase
Phase 1/2
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07281716 Combination Immunotherapy for the Treatment of Chemotherapy-refractory Metastatic MSS CRC Metastatic Microsatellite Stable Colorectal Carcinoma Recruiting
NCT07277322 Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases Metastatic Colorectal Cancer Recruiting
Disease Areas
Colorectal Cancer (1)
Get alerts when Dan Feng's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free